EssayResearch & science
What we mean when we say a drug "works"
Psychedelic trials report dramatic numbers. Understanding what those numbers measure — and what they quietly leave out — is the first step to reading them honestly.
Essays
Long-form writing, held to evidence
Pieces that take their time — about what the science shows, what it doesn’t, and what it asks of us.
EssayDepression & anxiety
Treatment-resistant
The clinical label describes what medicines have failed to do, not what a person is. That distinction changes how we read the research — and how we treat the people in it.
EssayTrauma & PTSD
The body keeps the appointment
Trauma is not only a memory problem. Understanding why it lives in the body helps explain why some emerging therapies work on the body's terms, not the mind's alone.
EssayPolicy & access
Who gets to be a patient?
If psychedelic therapy becomes a real treatment, the next question is not whether it works but who will be able to reach it — and whether access will follow need or money.
EssayPersonal stories
A clinician's first session, in her words
A therapist describes what it was actually like to sit with a patient through a supervised dosing session — the boredom, the fear, and the part nobody had prepared her for.
Essay
[object Object]
People imagine the dosing session as the climax of psychedelic therapy. In practice, clinicians often describe it as the prologue. What a person does with what they saw — over weeks, sometimes months — is where a temporary experience becomes a durable change, or fails to.